1361MO 8-month PSA strongly predicts outcomes of men with metastatic castration-sensitive prostate cancer in the PEACE-1 phase III trial

This article has no abstract
Epistemonikos ID: 5765f22d0c747bd0ad4e332147232b743d5fe7de
First added on: Feb 15, 2025